Close

Bristol-Myers Squibb (BMY), Ono Enter Settlement and License Agreement with Merck (MRK) to Resolve PD-1 Antibody Patent Litigation

January 20, 2017 4:02 PM EST Send to a Friend
Bristol-Myers Squibb Company (NYSE: BMY) and Ono Pharmaceutical Company, Ltd. today announced the companies have signed a global patent license ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login